87. Heart and Lung Transplants From HCV-Viremic Donors to Uninfected Patients: Longer-Term Follow-Up

BACKGROUND: The DONATE HCV Trial demonstrated that hearts and lungs can be safely transplanted from HCV-infected donors using a shortened, 4-week, pre-emptive course of direct-acting antivirals (DAA). The 6-month results from that study of 35 patients are encouraging, but longer-term data from a lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Woolley, Ann E, Goldberg, Hilary J, Singh, Steve K, Mehra, Mandeep R, Givertz, Michael M, Coppolino, Antonio, Cheng, Vivien, Fanikos, John, Harrington, David P, Mallidi, Hari R, Baden, Lindsey R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810410/
http://dx.doi.org/10.1093/ofid/ofz359.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810410/
http://dx.doi.org/10.1093/ofid/ofz359.011

Ejemplares similares